Active

ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE

Switched

BE0407622902

Rechtspersoon Non-profit association 1 establishment

Kantersteen 47, 1000 Brussel Activiteiten van bedrijfs- en werkgeversorganisaties

Active for

59 year, 10 months

Financials

Financial year 2025

Revenue

€ 10.4 million

▲ 4% vs 2024

Profit

Growing

€ 432,264

▲ 49% vs 2024

Debts

Low

€ 2.5 million

▲ 15% vs 2024

ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE from Brussel, company number BE0407622902, closed financial year 2025 with a result of € 432,264 after tax. For that financial year ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE recorded revenue of € 10.4 million and equity of € 6.7 million. Compared with financial year 2024, the result moved from € 289,650 to € 432,264. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What happened at ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?

What happened at ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Almirall NV stepped down as director. NBB
  • Amgen NV stepped down as director. NBB
  • MSD Belgium BVBA stepped down as director. NBB
  • Roche NV stepped down as director. NBB
  • Novo Nordisk pharma stepped down as director. NBB
  • UCB Pharma NV stepped down as director. NBB
  • Takeda Belgium Nv stepped down as director. NBB
  • Eli Lilly Benelux NV stepped down as director. NBB

In short

From € 1.2 million profit in 2021 to € 432,264 profit in 2025.

Paid € 265 in corporate taxes since 2021.

Best year ever: 2021, with € 1.2 million profit.

Pays suppliers within 54 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE? We notify you, reason included.

Follow ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

Sanofi Belgium NV

Director · represented by Bart Vermeulen

since 2023 · until 2026

Almirall NV

Director · represented by Gregory Paton

since 2025 · until 2028

Novartis Pharma NV

Director · represented by Federico Mambretti

since 2023 · until 2026

AstraZeneca NV

Director · represented by Angela Thompson

since 2023 · until 2026

Amgen NV

Director · represented by Sara Schaufelberger

since 2025 · until 2028

Eli Lilly Benelux NV

Chairman of the board · represented by Frédéric Clais

since 2024 · until 2027

MSD Belgium BVBA

Director · represented by Katrien De Vos

since 2025 · until 2028

Abbvie SA

Director · represented by Renaud Decroix

since 2024 · until 2027

Roche NV

Director · represented by Marie-José Borst

since 2025 · until 2028

Bristol-Myers Squibb Belgium SA

Director · represented by Sally McNab

since 2023 · until 2026

Novo Nordisk pharma

Director · represented by Axel De Muyt

since 2025 · until 2028

UCB Pharma NV

Vice-chairman of the board · represented by Xavier Hormaechea

Also active at: BIOWIN

since 2025 · until 2028

GlaxoSmithKline Pharmaceuticals SA

Director · represented by Frédéric Martin

since 2024 · until 2027

Takeda Belgium Nv

Director · represented by Bruno Rabilier

since 2025 · until 2028

Janssen-Cilag NV

Director · represented by Roxana Botea

since 2023 · until 2026

Bayer NV

Director · represented by Niels Hessmann

since 2024 · until 2027

Pfizer NV

Director · represented by Réginald Decraene

since 2024 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Kantersteen 47

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0407.622.902
VAT number
BE 0407.622.902
Registered office
Kantersteen 47, 1000 Brussel
Names & denominations
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE · A.G.I.M.A.V.G.I.
Enterprise type
Rechtspersoon
Legal form
Non-profit association
Legal situation
Normale toestand
Start date
26 October 1966
Peppol
Active · Active since 9 Dec 2025
Activities · NACE

Activiteiten van bedrijfs- en werkgeversorganisaties

Bedrijfs- en werkgeversorganisaties

Overige zakelijke dienstverlening, neg

Overige zakelijke dienstverlening, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?
The enterprise number of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE is BE0407622902.
What is the address of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?
The registered office of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE is located at Kantersteen 47, 1000 Brussel.
When was ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE founded?
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE was founded on 26 October 1966.
What is the main activity of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?
The main activity of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE is "Activiteiten van bedrijfs- en werkgeversorganisaties" (NACE code 94110).
Does ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE have a website?
No website is currently known for ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE.
How much profit did ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE make in 2025?
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE posted a profit after taxes of € 432,264 in financial year 2025.
What is the revenue of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?
In its most recent annual accounts (2025), ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE reported revenue of € 10,374,065.
How many employees does ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE have?
According to the 2025 annual accounts, ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE has 28.6 full-time equivalents (FTE).
Where can I find the annual accounts of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE?
According to the 2025 annual accounts, the directors of ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE are: Sanofi Belgium NV, Almirall NV, Novartis Pharma NV, AstraZeneca NV, Amgen NV, Eli Lilly Benelux NV, MSD Belgium BVBA, Abbvie SA.